| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 16.935 | 22.991 | 112.962 | 137.434 | 152.697 | 113.350 | 125.423 | 143.574 | 165.959 | 166.580 |
| Total Income - EUR | 16.935 | 22.991 | 114.393 | 139.223 | 154.221 | 117.109 | 127.427 | 145.960 | 169.162 | 169.105 |
| Total Expenses - EUR | 15.310 | 17.464 | 61.316 | 81.118 | 89.436 | 73.654 | 92.373 | 106.258 | 123.700 | 124.706 |
| Gross Profit/Loss - EUR | 1.624 | 5.528 | 53.077 | 58.105 | 64.785 | 43.455 | 35.054 | 39.702 | 45.462 | 44.399 |
| Net Profit/Loss - EUR | 1.116 | 5.068 | 51.933 | 56.712 | 63.453 | 42.553 | 34.272 | 38.564 | 44.271 | 35.806 |
| Employees | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 1 | 2 |
Check the financial reports for the company - Marylens Ofta Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.387 | 2.133 | 1.939 | 5.559 | 76.337 | 67.823 | 90.280 | 125.520 | 106.080 | 80.493 |
| Current Assets | 6.643 | 5.040 | 57.817 | 88.885 | 78.213 | 105.500 | 116.967 | 106.051 | 116.814 | 120.407 |
| Inventories | 0 | 0 | 5.981 | 6.235 | 5.567 | 3.088 | 6.076 | 7.337 | 6.911 | 12.478 |
| Receivables | 0 | 0 | 49 | 16.163 | 20.076 | 15.798 | 24.711 | 24.548 | 12.671 | 14.795 |
| Cash | 6.643 | 5.040 | 51.788 | 66.488 | 52.570 | 86.614 | 86.181 | 74.166 | 97.231 | 93.134 |
| Shareholders Funds | 7.916 | 5.872 | 51.945 | 87.798 | 137.228 | 167.466 | 155.467 | 109.133 | 157.809 | 39.773 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.114 | 1.301 | 7.811 | 6.646 | 17.323 | 5.856 | 51.780 | 122.438 | 65.085 | 161.127 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Marylens Ofta Srl